Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Active not recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 895Lung Neoplasms 610Small Cell Lung Carcinoma 167Colorectal Neoplasms 126Breast Neoplasms 107Melanoma 106Neoplasms 93Ovarian Neoplasms 92Neoplasm Metastasis 87Pancreatic Neoplasms 73Squamous Cell Carcinoma of Head and Neck 68Stomach Neoplasms 57Carcinoma, Renal Cell 56Head and Neck Neoplasms 54Endometrial Neoplasms 50Triple Negative Breast Neoplasms 49Esophageal Neoplasms 49Prostatic Neoplasms 46Uterine Cervical Neoplasms 42Urinary Bladder Neoplasms 40Colonic Neoplasms 40Mesothelioma 39Mesothelioma, Malignant 36Carcinoma, Hepatocellular 36Brain Neoplasms 33Sarcoma 29Carcinoma, Transitional Cell 28Adenocarcinoma of Lung 27Lung Diseases 26Disease 25

Interventions

Pemetrexed 2Carboplatin 2pembrolizumab 1patritumab deruxtecan 1durvalumab 1atezolizumab 1Taxes 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Non-Small Cell Lung Cancer Metastatic × Thoracic × 90 days × Clear all
NCT04163432 2026-05-19

STAGGER

University of Utah

Phase 2 Active not recruiting
43 enrolled 12 charts
Thoracic

Non-Small Cell Lung Cancer Metastatic

NCT04619004 2026-05-14

HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

Daiichi Sankyo

Phase 2 Active not recruiting
277 enrolled 16 charts
Thoracic

Non-Small Cell Lung Cancer Metastatic

NCT05689671 2026-03-10

ANTELOPE

Charite University, Berlin, Germany

Phase 4 Active not recruiting
136 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡